Rifabutin, a lesser-known cousin of the frontline tuberculosis drug rifampicin, may hold new life as a treatment option for multidrug-resistant...
For more than a decade, one of the most widely used statistical tools in environmental epidemiology has been available almost...
Researchers at the University of Warwick, in collaboration with clinicians from University Hospital North Midlands NHS Trust and Imperial College...
French neurologists have published a pragmatic guide for one of the most pressing unanswered questions in modern multiple sclerosis care:...
Cancer therapy saves lives, but it can quietly injure the blood vessels that keep the rest of the body alive....
Fabry disease has long been recognized as one of medicine's most insidious inherited disorders, a rare X-linked lysosomal storage condition...
The world's first approved blood test for Alzheimer's disease is facing a pointed scientific challenge. In a review published in...
Brain metastases strike up to 30 percent of cancer patients, bringing headaches, seizures, neurological deficits and a median survival of...
When a comatose patient survives a cardiac arrest, one of the most consequential questions in the intensive care unit is...
Positron emission tomography has long offered clinicians a window into the metabolic activity of the living human brain, but that...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine